vendredi 22 septembre 2017

Onco Actu du 22 septembre 2017

1. Biologie

Characterization of a Slowly Proliferating Population of Melanoma Cells with High Metastatic Properties [Wistar Institute]

How Mouse Models Pave the Way to Precision Cancer Medicine [Cancer Research Catalyst]

3.1 Prévention - Tabac

Smoking quit rates highest in 10 years [Cancer Research UK]

4.7 Dép., diag. & prono. - Col de l'utérus

FDA to Hold Meeting on Home Collection of Pap Smears: Possible Broader Implications? [FDA Law Blog]

5.1 Traitements - Pré-clinique

New Study Offers Novel Treatment Strategy for Patients with Colon Cancer [Boston University]

5.12.2 Immunothérapies - CAR-T

A New Model T on the Horizon? [Cell]

5.12.5 Immunothérapies - Pharma

Celgene-backed FLX picks CCR4 antagonist for clinical trials [FierceBiotech]

5.2.1 Pharma - Partenariats

Cancer biobank Indivumed and CRO Helomics team up on precision medicine [FierceBiotech]

5.2.3 Pharma - économie

Pfizer hits a snag in bid to jump-start Sutent's flagging kidney cancer sales [FiercePharma]

Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst [FiercePharma]

5.3.4 Traitements - AMM (FDA, EMA)

Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma [Roche]

European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma [Merck]

6. Lutte contre les cancers

Science Surgery: Will cancer ever be cured? [Cancer Research UK]

6.11 Patients

Giving patients a cancer diagnosis—what we need is more time [BMJ Blogs]